Amneal Pharmaceuticals: Q4 Earnings Insights

Amneal Pharmaceuticals (NASDAQ:AMRX) reported its Q4 earnings results on Friday, March 1, 2024 at 06:00 AM.

Here’s what investors need to know about the announcement.

Earnings

Amneal Pharmaceuticals beat estimated earnings by 56.00000000000001%, reporting an EPS of $0.14 versus an estimate of $0.09.

Revenue was up $7.22 million from the same period last …

Full story available on Benzinga.com